1:20 CBD+

1:20 CBD+ is a hybrid cannabis strain with up to 1.5% THC, known for its focused effects and citrus and earthy flavor profile.

1:20 CBD+ is a specialized cannabis strain bred specifically for its high cannabidiol (CBD) content and minimal tetrahydrocannabinol (THC) levels, resulting in a ratio of approximately 1 part THC to 20 parts CBD. This strain was developed through selective breeding programs focused on maximizing therapeutic potential while minimizing psychoactive effects. The exact genetic lineage is often proprietary information held by breeders, but it typically involves crossing high-CBD hemp varieties with carefully selected cannabis cultivars to achieve the desired cannabinoid profile while maintaining desirable terpene expressions and growth characteristics.

The strain produces medium-sized plants with dense, resinous buds that exhibit a range of green hues, often with orange pistils and a generous coating of trichomes. The appearance is typical of modern hybrid cannabis varieties, though the buds may be slightly less dense than high-THC counterparts due to the different cannabinoid production pathways. The aroma profile tends toward earthy and herbal notes with subtle citrus or floral undertones, reflecting its balanced terpene composition.

1:20 CBD+ represents a significant development in medical cannabis breeding, offering users access to CBD's potential therapeutic benefits without substantial psychoactive effects. This makes it particularly suitable for individuals seeking symptom relief while maintaining mental clarity and functionality. The strain has gained popularity in both medical and wellness circles as awareness of CBD's potential applications has grown, though it remains less common than balanced THC:CBD ratio strains in recreational markets.